Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford’s Primate Neuroscience research group and Biomedical Services team have been recognised for their openness and public engagement at Understanding Animal Research’s (UAR) fourth annual Openness Awards and the 81st Stephen Paget memorial lecture.

Image courtesy of Shutterstock

The Award for a Public Engagement Activity was presented jointly to the University of Oxford, MRC Harwell Institute, The Pirbright Institute and the University of Bristol, for coming together to open their labs to 3D cameras in order that the 360 degree Virtual Lab Animal Tour could be made.

Maria Martinez, the Primate Welfare Officer from the Biomedical Services Department said: ‘While animal research is necessary, is it essential for scientific, veterinary and animal care staff to continue to work closely together to maintain the highest standards of animal welfare. The virtual tour has been a great opportunity for Oxford to openly share the type research conducted in primates and the welfare standards that we maintain for our animals.'

Read more (University of Oxford website)

Similar stories

General anaesthesia should be available for dying patients - medical and ethical experts

General Research

General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Clinical Trials Coronavirus COVID-19 Research

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.